{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T11:01:18Z","timestamp":1768042878064,"version":"3.49.0"},"reference-count":34,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T00:00:00Z","timestamp":1679616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Spinal muscular atrophy (SMA) is an autosomal recessive disorder caused by the deletion or\/and mutation in the survival motor neuron 1 (SMN1) gene on chromosome 5. Until now, only a few articles investigating the relationship between upper limb function and the gross motor function in untreated SMA patients have been published. However, there is still a lack of publications including the relationship between structural changes such as cervical rotation, trunk rotation and side trunk shortening, and upper limb function. The aim of the study was to examine the upper limb function in patients with spinal muscular atrophy and the relationship between the upper limb function, gross motor function, and structural parameters. We present an analysis of 25 SMA patients, divided into sitter and walker groups, undergoing pharmacological treatment (nusinersen or risdiplam), examined twice between the initial examination and evaluation after a 12-month period. The participants were tested using validated scales such as the Revised Upper Limb Module (RULM), the Hammersmith Functional Motor Scale\u2014Extended (HFMSE), and the structural parameters. Our results showed that patients demonstrated greater improvement on the RULM scale than on the HFMSE scale. Moreover, persistent structural changes negatively affected both the upper limb function and gross motor skills.<\/jats:p>","DOI":"10.3390\/biomedicines11041005","type":"journal-article","created":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T03:50:21Z","timestamp":1679629821000},"page":"1005","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Examination of Upper Limb Function and the Relationship with Gross Motor Functional and Structural Parameters in Patients with Spinal Muscular Atrophy"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8298-6920","authenticated-orcid":false,"given":"Aleksandra","family":"Bieniaszewska","sequence":"first","affiliation":[{"name":"Department of Developmental Neurology, Poznan University of Medical Sciences, 60-355 Poznan, Poland"},{"name":"Doctoral School, Poznan University of Medical Sciences, Bukowska 70, 60-812 Poznan, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5341-8708","authenticated-orcid":false,"given":"Magdalena","family":"Sobieska","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation and Physiotherapy, Poznan University of Medical Sciences, 61-545 Poznan, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9839-8162","authenticated-orcid":false,"given":"Barbara","family":"Steinborn","sequence":"additional","affiliation":[{"name":"Department of Developmental Neurology, Poznan University of Medical Sciences, 60-355 Poznan, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9317-391X","authenticated-orcid":false,"given":"Ewa","family":"Gajewska","sequence":"additional","affiliation":[{"name":"Department of Developmental Neurology, Poznan University of Medical Sciences, 60-355 Poznan, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"6307","DOI":"10.1007\/s12035-017-0831-9","article-title":"Time Is Motor Neuron: Therapeutic Window and Its Correlation with Pathogenetic Mechanisms in Spinal Muscular Atrophy","volume":"55","author":"Govoni","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/gt.2017.45","article-title":"Therapeutic Approaches for Spinal Muscular Atrophy (SMA)","volume":"24","author":"Scoto","year":"2017","journal-title":"Gene Ther."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","article-title":"Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy","volume":"377","author":"Finkel","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"St\u0119pie\u0144, A., Gajewska, E., and Rekowski, W. (2021). Motor Function of Children with SMA1 and SMA2 Depends on the Neck and Trunk Muscle Strength, Deformation of the Spine, and the Range of Motion in the Limb Joints. Int. J. Environ. Res. Public. Health, 18.","DOI":"10.3390\/ijerph18179134"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5604\/15093492.933792","article-title":"Contractures of the Upper Extremities in Spinal Muscular Atrophy Type II. Descriptive Clinical Study with Retrospective Data Collection","volume":"13","author":"Fujak","year":"2011","journal-title":"Ortop. Traumatol. Rehabil."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","article-title":"Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy","volume":"377","author":"Mendell","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JND-190424","article-title":"Advances in Treatment of Spinal Muscular Atrophy\u2013New Phenotypes, New Challenges, New Implications for Care","volume":"7","author":"Schorling","year":"2020","journal-title":"J. Neuromuscul. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Chen, T.-H. (2020). New and Developing Therapies in Spinal Muscular Atrophy: From Genotype to Phenotype to Treatment and Where Do We Stand?. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21093297"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/mus.27384","article-title":"Different Trajectories in Upper Limb and Gross Motor Function in Spinal Muscular Atrophy","volume":"64","author":"Coratti","year":"2021","journal-title":"Muscle Nerve"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Bieniaszewska, A., Sobieska, M., and Gajewska, E. (2022). Prospective Analysis of Functional and Structural Changes in Patients with Spinal Muscular Atrophy\u2014A Pilot Study. Biomedicines, 10.","DOI":"10.3390\/biomedicines10123187"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.nmd.2021.10.009","article-title":"Revised Upper Limb Module in Type II and III Spinal Muscular Atrophy: 24-Month Changes","volume":"32","author":"Coratti","year":"2022","journal-title":"Neuromuscul. Disord."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/mus.25430","article-title":"Revised Upper Limb Module for Spinal Muscular Atrophy: Development of a New Module","volume":"55","author":"Mazzone","year":"2017","journal-title":"Muscle Nerve"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1090-3798(03)00060-6","article-title":"The Hammersmith Functional Motor Scale for Children with Spinal Muscular Atrophy: A Scale to Test Ability and Monitor Progress in Children with Limited Ambulation","volume":"7","author":"Main","year":"2003","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.nmd.2007.05.009","article-title":"An Expanded Version of the Hammersmith Functional Motor Scale for SMA II and III Patients","volume":"17","author":"Glanzman","year":"2007","journal-title":"Neuromuscul. Disord."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.nmd.2011.02.014","article-title":"Assessing Upper Limb Function in Nonambulant SMA Patients: Development of a New Module","volume":"21","author":"Mazzone","year":"2011","journal-title":"Neuromuscul. Disord."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.nmd.2014.11.008","article-title":"Upper Limb Module in Non-Ambulant Patients with Spinal Muscular Atrophy: 12 Month Changes","volume":"25","author":"Sivo","year":"2015","journal-title":"Neuromuscul. Disord."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.nmd.2005.11.010","article-title":"Reliability of the Hammersmith Functional Motor Scale for Spinal Muscular Atrophy in a Multicentric Study","volume":"16","author":"Mercuri","year":"2006","journal-title":"Neuromuscul. Disord."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"St\u0119pie\u0144, A., J\u0119drzejowska, M., Guzek, K., Rekowski, W., and St\u0119powska, J. (2019). Reliability of Four Tests to Assess Body Posture and the Range of Selected Movements in Individuals with Spinal Muscular Atrophy. BMC Musculoskelet. Disord., 20.","DOI":"10.1186\/s12891-018-2389-8"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1748-7161-5-12","article-title":"A Review of the Trunk Surface Metrics Used as Scoliosis and Other Deformities Evaluation Indices","volume":"5","author":"Patias","year":"2010","journal-title":"Scoliosis"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.20966\/chn.2019.56.437","article-title":"Przegl\u0105d metod oceny funkcjonalnej analizuj\u0105cych motoryk\u0119 ma\u0142\u0105 i du\u017c\u0105 u chorych z rdzeniowym zanikiem mi\u0119\u015bni","volume":"28","author":"Gajewska","year":"2019","journal-title":"Child Neurol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"(2013). World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. JAMA, 310, 2191.","DOI":"10.1001\/jama.2013.281053"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.nmd.2021.03.012","article-title":"Age Related Treatment Effect in Type II Spinal Muscular Atrophy Pediatric Patients Treated with Nusinersen","volume":"31","author":"Coratti","year":"2021","journal-title":"Neuromuscul. Disord."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/acn3.51514","article-title":"Nusinersen Efficacy Data for 24-month in Type 2 and 3 Spinal Muscular Atrophy","volume":"9","author":"Pane","year":"2022","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/mus.26419","article-title":"Revised Upper Limb Module for Spinal Muscular Atrophy: 12 Month Changes: 12 Month Changes on RULM for SMA","volume":"59","author":"Pera","year":"2019","journal-title":"Muscle Nerve"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/mus.27404","article-title":"Longitudinal Changes in Respiratory and Upper Limb Function in a Pediatric Type III Spinal Muscular Atrophy Cohort after Loss of Ambulation","volume":"64","author":"Wolfe","year":"2021","journal-title":"Muscle Nerve"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.nmd.2015.10.006","article-title":"Patterns of Disease Progression in Type 2 and 3 SMA: Implications for Clinical Trials","volume":"26","author":"Mercuri","year":"2016","journal-title":"Neuromuscul. Disord."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.nmd.2017.11.004","article-title":"Diagnosis and Management of Spinal Muscular Atrophy: Part 2: Pulmonary and Acute Care; Medications, Supplements and Immunizations; Other Organ Systems; and Ethics","volume":"28","author":"Finkel","year":"2018","journal-title":"Neuromuscul. Disord."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1177\/0883073807305788","article-title":"Consensus Statement for Standard of Care in Spinal Muscular Atrophy","volume":"22","author":"Wang","year":"2007","journal-title":"J. Child Neurol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.nmd.2017.11.005","article-title":"Diagnosis and Management of Spinal Muscular Atrophy: Part 1: Recommendations for Diagnosis, Rehabilitation, Orthopedic and Nutritional Care","volume":"28","author":"Mercuri","year":"2018","journal-title":"Neuromuscul. Disord."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Piccoli, A., Rossettini, G., Cecchetto, S., Viceconti, A., Ristori, D., Turolla, A., Maselli, F., and Testa, M. (2018). Effect of Attentional Focus Instructions on Motor Learning and Performance of Patients with Central Nervous System and Musculoskeletal Disorders: A Systematic Review. J. Funct. Morphol. Kinesiol., 3.","DOI":"10.3390\/jfmk3030040"},{"key":"ref_31","first-page":"6","article-title":"The Activities\/Tasks Performed by Health Care Aids in Hospital Settings: A Mixed-Methods Study","volume":"38","author":"Palese","year":"2019","journal-title":"Assist. Inferm. Ric."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.nmd.2022.02.001","article-title":"Evaluation of Real-Life Outcome Data of Patients with Spinal Muscular Atrophy Treated with Nusinersen in Switzerland","volume":"32","author":"Tscherter","year":"2022","journal-title":"Neuromuscul. Disord."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/mus.25120","article-title":"Six-Minute Walk Test Is Reliable and Valid in Spinal Muscular Atrophy: 6MWT in SMA","volume":"54","author":"Montes","year":"2016","journal-title":"Muscle Nerve"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e317","DOI":"10.1212\/CPJ.0000000000001033","article-title":"Nusinersen Treatment in Adults with Spinal Muscular Atrophy","volume":"11","author":"Duong","year":"2021","journal-title":"Neurol. Clin. Pract."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/11\/4\/1005\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:02:07Z","timestamp":1760122927000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/11\/4\/1005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,24]]},"references-count":34,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["biomedicines11041005"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines11041005","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,24]]}}}